QSAR in Cancer Assessment Purpose and Agenda G ilman Veith Duluth MN May 19-21, 2010
-
Upload
chastity-everett -
Category
Documents
-
view
20 -
download
0
description
Transcript of QSAR in Cancer Assessment Purpose and Agenda G ilman Veith Duluth MN May 19-21, 2010
QSAR in CANCER ASSESSMENT
PURPOSE and AGENDA
Gilman VeithDuluth MN
May 19-21, 2010
McKim Workshop Goals
Summarize regulatory contexts for hazard identification and risk estimation of carcinogenesis
Review progress on alternative methods for estimating endpoints needed in cancer assessment
Discuss the need for a mechanistic framework for improving the transparency of alternative models
Identify examples of chemical categories for which alternatives reliably predict outcomes of rodent assays
REGULATORY CONTEXTS
Precautionary Perspective
“What additional other test results would I want to see before I am willing to conclude a chemical is safe?”
Holistic Risk Perspective
“How can I identify greatest carcinogenic risks among all chemicals regardless of their testing status?”
HAZARD CLASSIFICATION CARCINOGENICITY
IARC
GHS
EPA
ACGIH
Description/Status of Available Data
1 1A 1 A1 Human carcinogen, definite, human studies
2A 1B 2 A2 Probably human, animal data multiple species, no epi data
2B 2 3 A3 Possibly human, suspected, some animal data
3 4 A4 Not classifiable, inadequate data to assess
4 5 A5 Probably not human, not suspected, no tumors in at least two species
HAZARD CLASSIFICATION CARCINOGENICITY
Carcinogenic to Humans (epi data required)
Likely to be Carcinogenic to Humans (tumors in two species)
Suggestive Evidence of Carcinogenic Potential
Inadequate Information to Assess Carcinogenic Potential
Not Likely to be Carcinogenic to Humans (no tumors in two species)
DATA DRIVEN HAZARD ASSESSMENT
CARCINOGENIC POTENTIAL
DATA DRIVEN HAZARD ASSESSMENT
CARCINOGENIC POTENTIAL
New Product
Development
Testing/AssessmentRequirements
NumberOfChemicals
Safety Assessment Process
INITIAL HAZARD ASSESSMENTS
Screening Information Datasets – SIDS
Globally Harmonised System of C&L – GHS
REACH –Dossier Testing Plan Reviews
TSCA –PMNs (predictive hazard identification)
QSAR in chemical engineering has always been used to focus attention/resources on specific activities
QSAR orders chemicals according to intrinsic attributes and generates initial hypotheses for more strategic use of testing and assessment resources
Structural alerts are a convenient and transparent approach to identifying hazard-specific priorities
STREAMLINING DATA REQUIREMENTS
MolecularInitiating
Events
Chemical Speciation
and
Metabolism
MeasurableBiological
Effects
Adverse Outcomes
ParentChemical
Conceptual Framework
Schultz et al. 2006. SAR QSAR in Environ.Res. 17(4) 1-16.
MolecularInitiating
Events
Speciation
and
Metabolism
MeasurableBiological
Effects
Adverse Outcomes
ParentChemical
Conceptual Framework
QSARQSAR ResponseResponsePathways Pathways
Chemistry/Chemistry/BiochemistryBiochemistry
MolecularInitiating
Events
Chemical Speciation
and
Metabolism
MeasurableBiological
Effects
Adverse Outcomes
ParentChemical
Conceptual Framework
Mortality-systemic toxicity
-disease-cancer
Impaired Development
-terata-prenatal deficits
Reproductive Fitness-fertility
-viable offspring
Chemical Inventories andCategories(~200,000)
InteractionMechanisms
-Nonspecific Targets
-Atom Center Targets
-Receptor Targets
MolecularInitiating
Events
Chemical Speciation
and
Metabolism
MeasurableBiological
Effects
Adverse Outcomes
ParentChemical
At the Molecular Initiating Event
The QSAR Question is:
“How many other chemicalscan interact at this target?”
While the Assessment Question is:
“What are the known biologicaleffects from this altered target….organelles, cells , organs, species ”
LibraryOf
MolecularInitiating
Events
Chemical Speciation
and
Metabolism
MeasurableBiological
Effects
Adverse Outcomes
ParentChemical
From the Library of Initiating Events
Chemical Chemical ProfilersProfilers
Available in Available in A Variety of A Variety of
Commercial & Commercial & Public Software Public Software
TargetsInteractions
Structural Requirements
Conformations
Metabolic SimulatorsInventories
LibraryOf
MolecularInitiating
Events
Chemical Speciation
and
Metabolism
MeasurableBiological
Effects
Adverse Outcomes
ParentChemical
From the Library of Initiating Events
DNABinding
Altered Genes/Proteins
Genetic Instability/
Cell Immortality
Acquisition ofTumorigenicity
PrematureDeath
GROUPING BY CANCER PATHWAYS
Genotoxic Carcinogenesis Direct DNA damage through abiotic chemical “binding” Most electrophiles bind to many DNA/protein sites Metabolic differences impact cell, organ, species
sensitivity
Epigenetic Carcinogenesis Cytoxicity-induced cell proliferation Receptor-mediated pathways Disturbance of homeostatic control Loss of immune surveillance Oxidative Stress- Indirect DNA damage Loss of intercellular communication
SCREENING LEVEL HAZARD ID
Direct DNA
Binding
Nongenotoxic
Mechanisms
ActivatedMetabolites
Indirect DNA
Damage
ParentChemica
l Individual
Initiating Events/Structur
al Alerts
Grouping Data for Interacti
onCategori
es
StructuralEvidence
of Cancer
Potential
Category with
Data for Cancer Potential
No EvidenceOf Cancer Potential
Simulated 2-Acetylaminofluorene
Metabolism
NH
O
NH
O
OH
NH
O
O
NH2
O
HO
O
NHOH
O
N+HO
NH
OHO
NH
O
O
NH
O
O
NH
OHO
NH
OHO
OHNH
OHO
OH
NH
OHO
O
NH
OHO
O
N+H
HO
ON+H
OH
O
. . . . . .
NHX
OO
X = H, OH,
O
Activated metabolites
Models for the Metabolism Gap
PATHWAYS IN REACTIVE CHEMICALS
MichaelAddition
Schiff baseFormation
SN2
Acylation
MichaelAddition
Schiff baseFormation
SN2
Acylation
AtomCentered
Irreversible(Covalent)Binding
AtomCentered
Irreversible(Covalent)Binding
InteractionMechanisms
MolecularInitiatingEvents
In vivoEndpoints
Pr-S AdductsGSH OxidationGSH DepletionNH2 AdductsRN AdductsDNA Adducts
Pr-S AdductsGSH OxidationGSH DepletionNH2 AdductsRN AdductsDNA Adducts
In vitroEndpoints
Death
ImpairedGrowth
Impaired Development
Impaired Reproduction
Cancer
Membrane Alteration
___
Oxidative Stress
___
Genotoxicity
OXIDATIVE STRESS from GSH DEPLETION
Pr-S Adducts
GSH Oxidation
GSH Depletion
NH2 Adducts
RN Adducts
DNA Adducts
Oxidative
Stress
Cell toxicit
y
Other Effects
DirectGSH
Reactions
AlteredSynthes
is
Oxidation
How Many Ways to Deplete GSH? How Many Downstream Effects?
Mode of Action
Receptor-mediated pathways
Disturbance of homeostaticcontrol
Loss of immune surveillance
Oxidative Stress- Indirect DNA damage
Loss of intercellular communication
Cytotoxicity-induced cell proliferation
GENOTOXICITY
Direct DNA Damage
Indirect DNA Damage
NON-GENOTOXICITY
Receptor-mediated pathways
Disturbance of homeostaticcontrol
Loss of immune surveillance
Oxidative Stress- Indirect DNA damage
Loss of intercellular communication
Cytotoxicity-induced cell proliferation
GENOTOXICITY
Direct DNA Damage
Indirect DNA Damage
NON-GENOTOXICITY
DNA Mechanism #1DNA Mechanism #2DNA Mechanism #3
DNA Mechanism #n……………………………
Prot Mechanism #1Prot Mechanism #2Prot Mechanism #3……………………………Prot Mechanism #n
AR BindingER BindingAromatase Inh.Thyroid Disturbance
Mechanism/AlertMode of action
Receptor-mediated pathways
Disturbance of homeostaticcontrol
Loss of immune surveillance
Oxidative Stress- Indirect DNA damage
Loss of intercellular communication
Cytotoxicity-induced cell proliferation
GENOTOXICITY
Direct DNA Damage
Indirect DNA Damage
NON-GENOTOXICITY
Mechanism/Alert
DNA #1DNA #2DNA #3
DNA #n………….
Prot #1Prot #2Prot #3…………..Prot #n
AR BindingER BindingAromatase Inh.Thyroid Disturbance
Mechanism/Metabolites
DNA Mechanism #1-Met 1…mDNA Mechanism #2-Met 1…mDNA Mechanism #3-Met 1…m
……………………………DNA Mechanism #3-Met 1…m
Prot Mechanism #1 - Met 1..mProt Mechanism #2 - Met 1..mProt Mechanism #3 - Met 1..m
……………………………Prot Mechanism #n - Met 1..m
Receptor-mediated pathways -Met 1…m
Disturbance of homeostatic control -Met 1…m
Loss of immune surveillance-Met 1…m
Oxidative Stress- Indirect DNA damage -Met 1…m
Loss of intercellular comm.-Met 1…m
Cytotoxicity-induced cell proliferation-Met 1…m
Mode of action
Receptor-mediated pathways
Disturbance of homeostaticcontrol
Loss of immune surveillance
Oxidative Stress- Indirect DNA damage
Loss of intercellular communication
Cytotoxicity-induced cell proliferation
GENOTOXICITY
Direct DNA Damage
Indirect DNA Damage
NON-GENOTOXICITY
Mechanism/Alert
DNA #1DNA #2DNA #3
DNA #n………….
Prot #1Prot #2Prot #3…………..Prot #n
AR BindingER BindingAromatase Inh.Thyroid Disturbance
Mechanism/Metabolites
Receptor-mediated pathways -Met 1…m
Disturbance of homeostatic control -Met 1…m
Loss of immune surveillance-Met 1…m
Oxidative Stress- Indirect DNA damage -Met 1…m
Loss of intercellular comm.-Met 1…m
Cytotoxicity-induced cell proliferation-Met 1…m
DNA #1-Met 1…mDNA #2-Met 1…m
……………………………DNA #3-Met 1…m
Prot #1 - Met 1..mProt #2 - Met 1..mProt #3 - Met 1..m……………………………Prot #n - Met 1..m
DNA #3-Met 1…m
In vitro data
Ames Ames+S9 CA CA+S9 MLA MLA+S9 CTA
Mode of action
Receptor-mediated pathways
Disturbance of homeostaticcontrol
Loss of immune surveillance
Oxidative Stress- Indirect DNA damage
Loss of intercellular communication
Cytotoxicity-induced cell proliferation
GENOTOXICITY
Direct DNA Damage
Indirect DNA Damage
NON-GENOTOXICITY
Mechanism/Alert
DNA #1DNA #2DNA #3
DNA #n………….
Prot #1Prot #2Prot #3…………..Prot #n
AR BindingER BindingAromatase Inh.Thyroid Disturbance
Mechanism/Metabolites
Receptor-mediated pathways -Met 1…m
Disturbance of homeostatic control -Met 1…m
Loss of immune surveillance-Met 1…m
Oxidative Stress- Indirect DNA damage -Met 1…m
Loss of intercellular comm.-Met 1…m
Cytotoxicity-induced cell proliferation-Met 1…m
DNA #1-Met 1…mDNA #2-Met 1…m
……………………………DNA #3-Met 1…m
Prot #1 - Met 1..mProt #2 - Met 1..mProt #3 - Met 1..m……………………………Prot #n - Met 1..m
DNA #3-Met 1…m
In vitro data
Ames
Ames+S9
CA
CA+S9
MLA
MLA+S9
CTA
In vivo data
COMET UDS CA MN(BN) CTA RCA
Mode of action